Johnson & Johnson (JNJ) stock profile

Frequently asked questions

What does Johnson & Johnson (JNJ) do?

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various healthcare products worldwide. In 2023, the company strategically separated its Consumer Health business into Kenvue Inc. to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands, including TYLENOL, LISTERINE, and BAND-AID, are now owned by Kenvue. The company's core focus is split between its Innovative Medicine segment (formerly Pharmaceutical), which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders, and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics, advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. The company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current headquarters in New Brunswick, New Jersey.

Where is JNJ stock listed?

Johnson & Johnson trades under the ticker JNJ on NYSE.

How can I research JNJ's financials and filings?

Vantafin provides Johnson & Johnson's income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the JNJ profile.